See more : CapitaLand China Trust (AU8U.SI) Income Statement Analysis – Financial Results
Complete financial analysis of DeepVerge plc (DVRG.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DeepVerge plc, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Mobcast Holdings Inc. (3664.T) Income Statement Analysis – Financial Results
- Autonomix Medical, Inc. Common Stock (AMIX) Income Statement Analysis – Financial Results
- PharmaRoth Labs, Inc. (ROTH) Income Statement Analysis – Financial Results
- CA Healthcare Acquisition Corp. (CAHC) Income Statement Analysis – Financial Results
- Kindly MD, Inc. (KDLY) Income Statement Analysis – Financial Results
DeepVerge plc (DVRG.L)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.deepverge.com
About DeepVerge plc
DeepVerge plc, an environmental and life science artificial intelligent company, develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus, and toxins. The company offers Labskin, a commercially available lab-grown, full thickness human skin to support product research and development activities in the cosmetic, personal care, medical device, and pharmaceutical sectors; Rinocloud, a data infrastructure as a service that delivers secure intelligent store, share and search, encryption, and infrastructure technologies; and skin trust club, a skin health tracking using advanced sequencing, bioinformatics, and AI algorithms. It also provides regulated environmental toxicology services; human skin equivalent platform to validate and verify the safety and impact on client products for regulatory authority approval; AI and microbiome platform to facilitate clinical trials for skincare companies and remote test-kits for consumer skin; and monitoring and data analytics platform for real-time detection and identification of pathogens in water and wastewater treatment plants, drinking water, rivers, lakes, and reservoirs. In addition, the company offers a range of skin care products and cannabinoid oils. It operates in the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Integumen Plc and changed its name to DeepVerge plc in October 2020. The company was incorporated in 2016 and is headquartered in Malahide, Ireland.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.30M | 4.48M | 823.00K | 274.00K | 238.00K | 52.06K | 55.87K | 661.00 | 2.31K |
| Cost of Revenue | 3.99M | 2.64M | 221.00K | 126.00K | 62.00K | 62.72K | 39.88K | 0.00 | 0.00 |
| Gross Profit | 5.31M | 1.84M | 602.00K | 148.00K | 176.00K | -10.65K | 15.98K | 661.00 | 2.31K |
| Gross Profit Ratio | 57.12% | 41.13% | 73.15% | 54.01% | 73.95% | -20.46% | 28.61% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.11M | 1.05M | 806.00K | 638.00K | 879.00K | 347.17K | 873.38K | 546.96K | 222.25K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.11M | 1.05M | 806.00K | 638.00K | 879.00K | 347.17K | 873.38K | 546.96K | 222.25K |
| Other Expenses | 6.53M | 2.72M | 1.37M | 951.00K | 1.65M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 8.64M | 3.77M | 2.18M | 1.59M | 2.53M | 911.35K | 853.62K | 546.96K | 209.78K |
| Cost & Expenses | 12.63M | 6.41M | 2.40M | 1.72M | 2.59M | 974.07K | 893.50K | 546.96K | 209.78K |
| Interest Income | 420.00 | 183.00 | 26.00 | 0.00 | 7.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 420.00K | 183.00K | 26.00K | 38.00K | 71.00K | 17.52K | 3.83K | 574.00 | 230.00 |
| Depreciation & Amortization | 3.32M | 1.06M | 518.00K | 617.00K | 7.60M | 118.96K | 68.91K | 4.14K | 0.00 |
| EBITDA | -12.00K | -858.00K | -1.06M | -798.00K | -1.91M | -888.00 | -768.72K | -542.15K | -207.47K |
| EBITDA Ratio | -0.13% | -19.14% | -128.19% | -767.15% | -800.84% | -1,485.15% | -1,376.01% | -82,020.12% | -8,985.19% |
| Operating Income | -3.33M | -1.92M | -1.57M | -1.44M | -2.35M | -1.08M | -837.63K | -546.30K | -207.47K |
| Operating Income Ratio | -35.80% | -42.87% | -191.13% | -525.91% | -987.82% | -2,068.84% | -1,499.36% | -82,647.05% | -8,985.19% |
| Total Other Income/Expenses | -420.00K | -978.00K | -824.00K | -679.00K | -7.23M | -1.09M | -3.83K | -574.00 | -230.00 |
| Income Before Tax | -3.68M | -2.90M | -2.40M | -2.12M | -9.58M | -1.09M | -841.47K | -546.87K | -207.70K |
| Income Before Tax Ratio | -39.58% | -64.69% | -291.25% | -773.72% | -4,025.63% | -2,102.50% | -1,506.22% | -82,733.89% | -8,995.15% |
| Income Tax Expense | -1.00M | -182.00K | -126.00K | -55.00K | -941.00K | -48.44K | 0.00 | 0.00 | 0.00 |
| Net Income | -2.68M | -2.72M | -2.27M | -2.70M | -8.64M | -1.05M | -841.47K | -546.87K | -207.70K |
| Net Income Ratio | -28.82% | -60.63% | -275.94% | -986.13% | -3,630.25% | -2,009.45% | -1,506.22% | -82,733.89% | -8,995.15% |
| EPS | -0.01 | -0.02 | -0.03 | -0.10 | -0.58 | -0.06 | -0.05 | -0.03 | -0.01 |
| EPS Diluted | -0.01 | -0.02 | -0.03 | -0.10 | -0.58 | -0.06 | -0.05 | -0.03 | -0.01 |
| Weighted Avg Shares Out | 196.93M | 128.72M | 80.74M | 25.87M | 14.80M | 16.51M | 16.51M | 16.51M | 16.51M |
| Weighted Avg Shares Out (Dil) | 196.93M | 128.72M | 80.74M | 25.87M | 14.80M | 16.51M | 16.51M | 16.51M | 16.51M |
Source: https://incomestatements.info
Category: Stock Reports